Long-term use of adalimumab in the treatment of rheumatic diseases

Adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor-alpha (TNFα), has been evaluated in various randomized placebo-controlled trials in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis. In the short time frame of these tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Papagoras, Charalampos, Voulgari, Paraskevi V, Drosos, Alexandros A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074727/
https://www.ncbi.nlm.nih.gov/pubmed/27789981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074727/
https://www.ncbi.nlm.nih.gov/pubmed/27789981

Ejemplares similares